Matilde Sinibaldi - Concepedia

Author

Matilde Sinibaldi

Bambino Gesù Children's Hospital ORCID

Also Known As

M. Sinibaldi, Matilde Sinibaldi

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Bambino Gesù Children's Hospital Istituti di Ricovero e Cura a Carattere Scientifico University of Naples Federico II Sapienza University of Rome Università Cattolica del Sacro Cuore

About

Matilde Sinibaldi is an author at Bambino Gesù Children's Hospital specializing in autoimmunity, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	181
2	Cell Biology	2	2	161
3	Allergy	1	1	20
4	Cellular Physiology	1	1	69
5	Cellular Therapies	1	1	92

Matilde Sinibaldi

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma Francesca Del Bufalo, Biagio De Angelis, Ignazio Caruana, New England Journal of Medicine	2023	482
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma Concetta Quintarelli, Domenico Orlando, Iolanda Boffa, OncoImmunology	2018	148
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia Simona Caruso, Biagio De Angelis, Francesca Del Bufalo, Journal of Hematology & Oncology	2022	110
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia Concetta Quintarelli, Simona Sivori, Simona Caruso, Leukemia Hematological MalignancyCell TherapyMalignant Blood DisorderHematologyImmunology	2019	92
Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma Domenico Orlando, Evelina Miele, Biagio De Angelis, Cancer Research	2018	75
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells Marika Guercio, Domenico Orlando, Stefano Di Cecca, Haematologica Adaptive Immune SystemT-regulatory CellImmunologyImmunologic MechanismCd4 T Cell Responses	2020	69
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies Marika Guercio, Simona Manni, Iolanda Boffa, Frontiers in Immunology	2021	63
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies Carlos A. García‐Prieto, Lorea Villanueva, Alberto Bueno-Costa, JNCI Journal of the National Cancer Institute	2021	57
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies Simona Manni, Francesca Del Bufalo, Pietro Merli, Nature Communications	2023	51
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis Rebecca Nicolai, Pietro Merli, Patricia Morán Álvarez, Arthritis & Rheumatology	2024	40

Page 1